chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10 minutes after imms given patient complained of dizziness & severe headache - laid down - dizziness resolved after 30 minutes - headache remained. Pt. went home to rest - headache resolved that evening - felt better 1-16-13 AM.
On the evening of 10JAN2021, patient experienced a low grade fever, decreased oxygen saturation of 38%, heart rate of 124, confusion.  Patient received oxygen via face mask, morphine and ativan.  By 11JAN2021, patient was no longer verbal, able to eat or communicate and was kept on comfort measure only. On the morning of 17JAN2021, the patient passed away.
Redness and swelling at site of immunization.  Seen in office 3 days after immunization given.  Treated with Keflex for possible wound infection.
I was out of town on a three-day trip and started having trouble breathing. My legs started swelling on the last day. I flew home and I went directly to the emergency room where they admitted me. They drained eight pounds of water off of me. They ran an EKG, chest x-ray, stress test. After staying in the hospital for three days I was discharged, I was given LASIX to take if I gained more than three pounds. I was also given losartan to take and diagnosed, with diastolic heart failure and high blood pressure.
pt recv vax 15MAY96 & 2 days later, devel inj site rxn characterized by redness & a lump;this is one to two pt from this site to exp inj site rxn p/vax;
Temperature at 99.2 F at noon today; Moderate to severe diarrhea beginning the morning after injection.; Pain in the upper left arm around the injection site. Wosened over night.; Pain when using arm.; Light nausea; Unable to sleep on the left side because of this.; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, IBS, ADHD and depression. Concomitant medications included methylphenidate 54 (MANUFACTURER UNKNOWN) and fluoxetine 50 (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 13:00, the patient experienced pain in the upper left arm around the injection site, worsening with pressure beyond the expected level for an injection that worsened over night, pain when using arm, unable to sleep on the left side because of pain and light nausea. On 07Apr2021, the patient experienced moderate to severe diarrhea beginning the morning after injection. Despite having IBS, it was not accompanied with the intense cramps that an IBS episode usually would have. On 07Apr2021 at noon, the body temperature was reported as 99.2 F (Fahrenheit). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events moderate to severe diarrhea, pain in the upper left arm around the injection site, pain when using arm, unable to sleep on the left side because of pain, light nausea and temperature at 99.2 F was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
TOOK VIVOTIF EVERY DAY INSTEAD OF EVERY OTHER DAY; This spontaneous case report (PVX2019-2517) was received from a pharmacist on 08-Oct-2019. It described a 49-year-old adult female consumer who "took Vivotif every day instead of every other day" (PT: Inappropriate schedule of product administration). The consumer was receiving oral Vivotif capsule for typhoid prophylaxis.  Case report: The consumer took all the doses of Vivotif every day instead of every other day. The doses were taken from 04-Oct-2019 to 07-Oct-2019.  Action taken with Vivotif with respect to the event was not applicable.  The clinical outcome of the reported event was unknown.  Company's Comment: The causality of the event "took Vivotif every day instead of every other day" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took Vivotif every day instead of every other day" was considered as not applicable.
Fever (102). Maculopapular rash - 11 days after MMR.
Information has been received from a registered nurse herself and via a company representative concerning a 17 year old female patient who on 20-JUN-2007 was vaccinated with the first dose of Gardasil (Lot # 0212U). On 21-JUN-2007, the morning following vaccination, the patient called the office and reported that she was pale, had low blood pressure (value not specified), had nausea, was weak and had a headache. On 22-JUN-2007, the patient had recovered from the events. The patient sought unspecified medical attention. Additional information has been requested. Initial and follow-up information has been received from a licensed visiting nurse, concerning a 17 year old female student with a penicillina allergy and no illness at the time of vaccination, who on 20-JUN-2007 at 3:15pm, was vaccinated IM in the right buttock, with
has been severely sick since getting the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "has been severely sick since getting the vaccine". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
While giving a Covid vaccine needle and hub separated from the syringe and product went on pts arm instead of in.  Re vaccinated him.
facial flushness; eyes got blood shot/ eye redness; This is a spontaneous report from a contactable consumer (patient's husband). A 72-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, administered in left arm, on 21Feb2021 (at the age of 72 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 21Feb2021, it was reported that the patient experienced facial flushness, with eye redness that started immediately after the vaccine. The patient's eyes got blood shot and she had not heard of that, and queried if was that something new or a normal side effect. The outcome of the event was recovered on 21Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
3/5/2021 Patient began feeling pain in arm where dose one of COVID Vaccine Pfizer was injected. 3/7/2021 evening of 3/7/2021 patient noticed a bump begin on injection site. 3/8/2021 pain and bump still  present according to Patient.
Area around the left arm pit swollen it was bland and it presented as a slight discomfort; Area around the left arm pit swollen it was bland and it presented as a slight discomfort; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Jun2023 as dose 3 (booster), single (Lot number: GJ3270) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing); "covid prior vaccination" (unspecified if ongoing). Concomitant medication(s) included: ASPIRIN PROTECT; VITAMIN D [ERGOCALCIFEROL]. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW8736, Location of injection: Arm Left), administration date: 22Apr2021, when the patient was 41-year-old, for Covid-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EE0178, Location of injection: Arm Left), administration date: 20May2021, when the patient was 41-year-old, for Covid-19 immunization. The following information was reported: SWELLING (non-serious), AXILLARY PAIN (non-serious) all with onset 19Jun2023 at 10:00, outcome "not recovered" and all described as "Area around the left arm pit swollen it was bland and it presented as a slight discomfort". Therapeutic measures were taken as a result of swelling, axillary pain.  Additional Information: The day after the vaccine the patient had the area around the left arm pit swollen it was bland and it presented as a slight discomfort. He took some ibuprofen for 2 days to see if the swelling reduces but changed to an anti-inflammatory and 3 days later it still was swollen.
Dizziness, clammy, hypotension, bradycardia, weak--transferred to local ED for observation, later discharged with no treatment.
A few days after I got the shot, maybe a week, I noticed I wasn't seeing out of my left eye, it was blurred and felt like and still feels like it has a film over it.  I do wear corrective lenses and I had my annual eye exam and ordered some new glasses shortly before  vaccination.  At first I thought it was the glasses, but problem persisted even with glasses off.
Within 24 hrs of vaccine, pt developed myalgia, arthralgias.He has since developed a large red erythematous hot rash and has difficulty moving L/elbow.The pt has some mild fluid in the olecranon bursa in the L/elbow. (See comments.)
Dose of 12+ Pfizer formulation inadvertently given to a 10yo client. Family reported no adverse effects as of 2 days after vaccination
CLIENT RECIEVED HIS SECOND DOSE 5 DAYS EARLIER THAN HE WAS ABLE TO.  CLIENTS FIRST DOSE WAS ADMINISTERED ON 12/23.
Acute severe reactive lymphadenpathy secondary to recent covid vaccine booster. Patient initially had J&J vaccine several months ago and had Pfizer vaccine as a booster.. Adverse effect after Pfizer booster
This spontaneous report as received from a pharmacist refers to a 2 months old female patient. The patient was vaccinated intramuscularly into the right deltoid with 0.5 ml PNEUMOVAX 23 (lot number 0087AE, expiration date 18-AUG-2013) on 31-JUL-2012. No other co-suspects or concomitant medications were reported. On 31-JUL-2012 the patient was inadvertently vaccinated with PNEUMOVAX 23 instead of PREVNAR. No adverse effects reported at the time of report. Pharmacist stated parents of the child had been contacted. Parents would bring child back in one month for the PREVNAR and for a follow up. The patient's sibling case was captured in MARRS# 1208USA002354. Additional information has been requested.
Reported chills, fever 100.8F, loss of appetite, and muscle aches.
Oth complications following immunization, NEC, init on 2017-10-16.
developed a fever that kept climbing; breastfed; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (developed a fever that kept climbing) and EXPOSURE VIA BREAST MILK (breastfed) in a 5-month-old female infant exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the infant was diagnosed with PYREXIA (developed a fever that kept climbing) and EXPOSURE VIA BREAST MILK (breastfed). The Infant was exposed to mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, PYREXIA (developed a fever that kept climbing) and EXPOSURE VIA BREAST MILK (breastfed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-089747 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-089747:case for daughter
Patient began to feel dizzy following vaccination. He was brought to lay down and vital signs were taken. Patient drank water, sat up and felt improved. He was assessed by medical director and left to go home.
CHILLS CHILLS STARTED AGAIN ON FEB 7 AND CONTINUE ON FEB 8
This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination. No Medical History was Reported. On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 4 dosage form and PARACETAMOL (TYLENOL) at a dose of 11 dosage form. At the time of the report, MYALGIA (body pain), PYREXIA (high fever), HEADACHE (head hurts bad) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported.
Heart palpitations and syncope. Blood work, PCP visits x2. PCP requested I wear a Holter monitor x30 days but could not afford it.
3APR96 1hr p/taking second typhoid pill devel itchiness & 6 hives erupted;sx lasted about 24hr
Worker received the Janssen vaccine on 8/17/21. While entering data into  program, it was noted that the worker had previously received the 2-dose Moderna vaccine on 4/16/21 and 5/18/21 after the Janssen dose was administered.
Within a few minutes after receiving the vaccine my arm felt stiff and some soreness. Then it fine after I got home and I moved my arm around. It was fine by the next day. Yesterday I ate some shrimp and within the hour of eating the shrimp, I was talking to my son  and my head got hot and my ears got really hot. It was itching on my forehead and the front of my neck. I thought something bite me, I went to bathroom. I had big welts on my neck about the size of the quarter and my ears were really red. I told my son that I must have hives, my son told me to take some Benadryl. It eased up after taking the Benadryl, the itching went away but the welts did not go away right away. I took another Benadryl before I went to bed last night. I was able to sleep good last night, it looked pretty much back to normal today, there is one spot left. Today when I got up I don't know how to explain it and I just didn't feel like my normal self. I felt like nervous and shaking. I didn't feel like eating but I made my self eat.  I just feel like something isn't right.
Sometime in October, my vision started to get dark. Words were being curved instead of straight across. I went to my doctor and they gave me an injection of my eye and every 3 months I have to go back. It is in my right eye. I was diagnosis was emasculate degeneration. The treatment has cleared up the darkness but I still do see the curvy lines.
Large local reaction to left thigh of injection (DTAP site)  - red, warm, and painful. Pt went to ER and noted to be 8 cm in diameter. Told to do cold compresses and Motrin. Returned next day to ER and 10 cm in diameter and given Augmentin and oral steroids with Benadryl. I asked her to hold off on giving Augmentin another 24 hrs as likely local reaction.
Patient had rash on backs of hands, forearms and face with itching. Claims reaction due to shot. Reported reaction on 10-13-14. Says reaction started evening of 10/9. Recommended BENADRYL and hydrocortisone cream.
11:50 that evening,  severe chills,  arm sore, headache.  Next day felt achy, chills et in again 2:00pm and 10:00 102.4 fever.
Pfizer-BioNTech COVID-19 Vaccine EUA.      Chills and low grade fever about 11 hrs after being vaccinated and the worse body aches I have ever had and tiredness and a splitting headache.    Took some tylenol when I finally got out of bed at about 11:30 a.m. on the 24th, then at around 4:00 p.m. the same day, I started getting chills again, headache and ran 102.6 fever for about 2 hours, then fever gradually went down and was gone by 10:00 p.m. on 24th.  The actual body aches finally started to diminish at the same time.
20 minutes after vaccination facial hotness and flushing similar to drug allergy, scratchy throat, severe headache, wheezing.  I used asthma inhaler on way home.  When got  home took 2 benadryl and ate lunch.  2 hours later took 2 ibuprofen, used home nebulizer and took a nap.  The benadryl stopped reaction but took a while for wheezing to abate.  Also very tired the next day, with still some arm soreness.
Vial of Pfizer was not diluted prior to administration and 0.3ml was pulled from vial and administered to patient.
One day after the patient (My mother) who was a CLL patient for about 9 years received the pfizer vaccine she started feeling dizzy which lead to her being unconscious in the bathroom and falling. The same day she had urinary incontinence and slightly slurred speech. The next day she was hospitalized and remained hospitalized for 6 days receiving several medications and performing several MRI?s and CT scans. MRI?s showed demyelination and her slurred speech has increased until the 7th day she was in huge pain had to take morphine, said that it felt like her chest was going to explode and she wasnt very alert also she said her heart hurt then a few hours later in the hospital her heart stopped even after several resuscitation trials. Doctors said that ADEM was cause of death even though its very rare she is literally the 8th patient worldwide. Please note that she received a different COVID vaccine in october and nothing happened but then was obligated to receive your vaccine in a different Country Please why is the vaccine forced upon people who are likely to die after taking it please stop this i cant get my mother back but other people can be saved
This report described the occurrence of back pain in a 51 year old female patient who received Lyme disease vaccine recombinant for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The patient submitted a report directly to VAERS. The patient's medical history included heel spurs and under active thyroid. Concurrent medications included nabumetone, ibuprofen, levothyroxine, and estradiol. On a VAERS form completed by the patient on 3/14/03, she indicated that she received SC injections of Lymerix on 6/4/99, 7/8/99, and 7/8/00. Lymerix is not recommended for SC administration. The patient indicated that her adverse experience began in Fall 2001. For the description of the event, she wrote, "Fatigue, muscle and joint pain, problems sleeping, memory problems." She indicated that the outcome of these events was unknown. On 9/3/03, the patient's attorney stated, "Vaccinations occurred on 7/3/99, 7/8/99, and 7/8/00 according to the client." The attorney alleged that the patient's symptoms were masked by Relafen and Motrin which she was taking for heel [sic] spurs. She recognized her symptoms in the fall of 2001. She suffered back, shoulder, elbow and neck pain, memory problems and insomnia. The patient is HLA DR4 positive. The following information was provided via medical records. Medical history included joint pain, neck pain, and fatigue, in addition to Lyme disease versus fibromyalgia versus chronic fatigue syndrome (documented as past medical history upon evaluation on 7/22/02). Dates of onset for these medical history events were not provided. According to records, the patient received Lymerix vaccinations on 6/3/99, 7/8/99, and 6/8/00 (the patient's attorney reported that the third Lymerix vaccination had been administered on 7/8/00). On 6/24/99, three weeks after the initial Lymerix vaccination, the patient presented with complaints of fatigue. The patient developed joint pain in multiple joints, and was evaluated for these complaints on 8/27/01, 7/29/02, and 1/30/03. As recently as 1/30/03, the patient continued to experience multiple joint pain. Medical records dated 5/5/03 indicated that the patient had experienced a Lyme vaccine reaction. Following the reported onset of back pain, the patient experienced upper respiratory infection, colon polyp, and pharyngitis. She also complained of moodiness/irritability and a fluttery feeling in her chest on 6/24/99, the same date she was evaluated for fatigue. These were not reported as adverse events due to vaccine administration, but were found during the course of review of the patient's medical records. Therefore, they are not listed as adverse events. The most recent information received on 12/8/03 did not provide the outcome of the reported events.
pain in the arm; fever; pain in bones; general discomfort; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number and expiration date was not reported), via an unspecified route of administration on 22Feb2021 as dose number unknown, single for COVID-19 immunisation. Medical history was not reported. Concomitant medication was not reported. On 23Feb2021, the patient experienced pain in the arm, fever, pain in bones and general discomfort. Caller was asking in regards of her mother who received the vaccine yesterday, she wants to know if it was safe for the patient to take Ibuprofen to treat her symptoms and today morning she presented the following side effects: pain in the arm, fever, pain in bones and general discomfort. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient called on 1/24/14 describing a red, warm rash on shoulder and chest that developed 1-2 days after getting a flu shot. I encouraged him to see a doctor to have the rash evaluated. Prescriptions filled on 1/26/14 indicate the rash is shingles. I tried to call the patient for follow up on 1/27/14 but there was no answer.
Vaccine was given outside the manufacturer's recommended window. Patient doing ok and wants revaccinated in the fall.
Starting about 10 hours after receiving the shot, I experienced a horrible headache, low grade fever, upset stomach, and severe body aches.
A female reported that she received Pnu-Imune 23 and Influenzae virus vaccines on 12/02/00. That same day, she experienced a headache, feeling sick to the stomach, weakness, dizziness, and a stiff neck. She also experienced "severe" pain from her right shoulder extending down her hand and up to the side of her neck to her skull. In addition, her hand became "purple in color" and she developed an injection site reaction characterized by redness and warmth at the site of Pnu-Imune 23 administration. She was seen by a physician who reportedly attributed the events to a reaction to the Pnu-Imune 23 injection.
Approx 3hrs post vax c/o being cold & had chills bumps; mom took outside & noticed child rolled her eyes back but did not LOC, mom took to local ER-t103.4; MD called incident feb sz due to Pertussis;